Site-specific modification of ED-B-targeting antibody using intein-fusion technology

Overview of attention for article published in BMC Biotechnology, July 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 6 patents

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 61 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 6 patents that reference this research output.

CYSTEINE-FREE INTEINS

Application WO-2020249723-A1

World Intellectual Property Organisation (WIPO)

CYSTEINE-FREE INTEINS

Application EP-3750911-A1

European Patent Office

METHOD FOR EXPRESSING AND PREPARING POLYVALENT MULTI-SPECIFIC ANTIBODY AND IMMUNE HYBRID…

Application EP-3421500-A4

European Patent Office

BIVALENT BISPECIFIC ANTIBODY HYBRID PROTEIN EXPRESSION AND PREPARATION METHODS

Application EP-3418305-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 2 additional patents.